Kyle Griffin @kylegriffin1
Merck will apply for an FDA emergency use authorization "as soon as possible" for its experimental oral antiviral pill for COVID. The company says the pill reduced the risk of hospitalization or death by around 50% in a clinical trial. — PolitiTweet.org